NEWLY DIAGNOSED
Clinical trials for NEWLY DIAGNOSED explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill may keep ovarian cancer at bay for longer in BRCA patients
Disease control OngoingThis study tests whether taking olaparib daily after initial chemotherapy can delay cancer growth in people with advanced ovarian cancer who have a BRCA gene mutation. About 450 participants who responded well to first-line platinum chemo will receive either olaparib or a placebo…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 10:47 UTC
-
New drug combo shows promise in battle against deadly brain tumors
Disease control OngoingThis early-phase trial tests a new drug called selinexor alongside standard radiation and chemotherapy for people with newly diagnosed glioblastoma, an aggressive brain cancer. The main goal is to find the highest safe dose of selinexor that can be given with these treatments. Ab…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:55 UTC